Eurycoma Longifolia Root US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006041
Compound index — E
660 substances begin with E. 8 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 60 of them, Eurycoma Longifolia Root – Ezogabine.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Eurycoma Longifolia Whole US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAndrogen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006042
Euspongia officinalis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006043
Euterpe edulis EU-NOVEL Not yet graded
Not novel in food
also: Euterpe edulis var. clausa Mattos
Parts in scopeFruits (botanically berries)
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-006044
Euterpe oleracea CA-NHP Not yet graded
CA licensed ingredient
Market presence955 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006045
Euterpe oleracea Mart. (Arecaceae). CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006046
Euterpe spp. EU-NOVEL Not yet graded
Not novel in food
Parts in scopeFruits (botanically berries)
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-006047
Eutrema japonica CA-NHP Not yet graded
CA licensed ingredient
Market presence35 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006048
Eutrema Japonicum CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006049
Eutrema japonicum EU-NOVEL Not yet graded
Eutrema scapiflorum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006051
Eutrochium Purpureum Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006052
Eutylone US-CSA Not yet graded
CSA Schedule I
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other names1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one; bk-EBDB
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-006053
Evans Blue US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006054
Evening Primrose Oil (EPO), Oenothera spp. and Fish Oil (FO) providing long chain omega 6 and omega 3 fatty acids [gamma-linolenic acid (GLA) and eicosapentaenoic acid (EPA)] EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps maintain joint mobility.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006057
Evening primrose oil (Oenothera biennis) contains gamalinolenic acid EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “helps to keep normal blood cholesterol” | Non-authorised | Art.13(1) | EFSA opinion |
| “helps to keep normal blood preassure” | Non-authorised | Art.13(1) | EFSA opinion |
| “helps to maintain proper appearence of skin, helps to maintain elasticity, tenderness and health of skin” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006056
Evening primrose oil and fish oil EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps maintain bone strength/helps maintain bone density and strength by increasing intestinal calcium absorption and reducing urinary calcium excretion” | Non-authorised | Art.13(1) | EFSA opinion |
| “helps maintain bone density and strength by increasing intestinal calcium absorption” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006055
Everlasting Extract US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006058
Evernia Prunastri US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006059
Everolimus EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedCytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]
Earliest US approval2009
Market presence112 US product listings · 22 FDA applications · 2 EU medicines
Etalyn identifierETA-C-006060
Evinacumab-Dgnb US-DRUG Not yet graded
Earliest US approval2021
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006062
Evodia rutaecarpa CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006064
Evodiae pteleaefolia CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006065
Evolocumab EU-MEDUS-DRUG Not yet graded
Evolvulus alsinoides CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006067
ex vivo expanded autologous human corneal epithelial cells containing stem cells EU-MED Not yet graded
EU medicine: Authorised
Class as recordedS01XA19
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006068
ex vivo-expanded EU-MED Not yet graded
EU medicine: Opinion
Class as recordedL01XL
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006069
Examorelin US-DRUG Not yet graded
US: bulk ingredient
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006071
Exemestane US-DRUG Not yet graded
US: anda
Class as recordedAromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]
Earliest US approval1999
Market presence26 US product listings · 12 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006072
Exenatide EU-MEDUS-DRUG Not yet graded
Exenatide Synthetic US-DRUG Not yet graded
Earliest US approval2005
Market presence5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006074
Exogenous ketones ETALYN B/not supportedband 5
also: ketone monoesters; beta-hydroxybutyrate salts
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-006075
expressing Dengue virus EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BX04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006076
expressing feline interleukin-2 gene EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006077
expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006078
expressing haemagglutinin gene of Avian influenza subtype H5 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006079
expressing infectious bursal disease virus and avian infectious laryngotracheitis virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006080
expressing infectious bursal disease virus VP2 protein EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006081
expressing slime-associated antigenic complex EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006082
expressing the capsid protein of porcine circovirus type 2a EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006083
expressing the F protein gene of Newcastle disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006084
expressing the fusion protein gene of Newcastle disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006085
expressing the fusion protein of ND virus and the VP2 protein of IBD virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006086
expressing the fusion protein of Newcastle disease virus and the VP2 protein of infectious bursal disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006087
expressing the glycoproteins gD and gI of infectious laryngotracheitis virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006088
expressing the VP2 protein gene of Infectious bursal disease virus and haemagglutinin gene of Avian influenza virus subtype H5 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006089
expressing the VP2 protein of IBDV and the F protein of NDV EU-MED Not yet graded
EU medicine: Authorised
Class as recordedQI01AD16
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006090
expressing the VP2 protein of infectious bursal disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006091
Extract from the red grapes skin EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to protect cells from the free-radical damage Helps to protect cells from the damage caused by free-radical” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006092
extract of guarana (Paullinia cupana) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “natural antioxidant, protect organism from oxidative damage, powerful antioxidants beneficial to human health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006093
Extract of Ox Bile CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006094
Extract of the liver and heart of Annas barbariae CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006095
extraction solvent n-heptane 95% (w/w) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedD03AX13
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006096
Eye q baby®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Eye q baby® provides the nourishments that support healthy central nervous system development” | Non-authorised | Art.14(1)(b) | EFSA opinion |
| “Eye q® provides the nourishments that help to maintain healthy brain functions” | Non-authorised | Art.14(1)(b) | EFSA opinion |
| “Eye q® provides the nourishment that help children to maintain concentration levels” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006097
Eye q, containing a combination of eicosapentaenoic acid, docosahexaenoic acid, and gamma-linolenic acid EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Eye q (a unique combination of High-EPA/DHA/GLA omega-3, 6 PUFA) provides the essential nutrients that helps improve working memory in children” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006098
Ezetimibe EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, OpinionUS: anda
Class as recordedAdenosine Triphosphate-Citrate Lyase Inhibitor [EPC]; Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]; C10B; Decreased Cholesterol Absorption [PE]
Earliest US approval2002
Market presence106 US product listings · 31 FDA applications · 2 EU medicines
Etalyn identifierETA-C-006099